[CYCC] YoY Quarter Result on 31-Mar-2008 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
09-May-2008
Financial Year
2008
Quarter
31-Mar-2008 [#Q1]
Profit Trend
QoQ- 44.94%
YoY- -27.85%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Revenue 192 271 228 177 52 151 16 51.27%
PBT -4,779 -5,244 -5,421 -6,927 -5,442 -11,709 -7,292 -6.79%
Tax -191 -133 -358 -675 -552 -360 -206 -1.25%
NP -4,588 -5,111 -5,063 -6,252 -4,890 -11,349 -7,292 -7.42%
Tax Rate - - - - - - - -
Total Cost 4,780 5,382 5,291 6,429 4,942 11,500 7,308 -6.82%
Ratio Analysis
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
NP Margin -2,389.58 -1,885.98 -2,220.61 -3,532.20 -9,403.85 -7,515.89 -45,575.00 -38.80%
Per Share
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
EPS -165.51 -270.70 -416.30 -514.06 -451.69 -2,429.67 -1,578.70 -31.32%
EPS Diluted -165.51 -270.70 -416.30 -514.06 -451.69 -2,429.67 -1,578.70 -31.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.